Investing.com – Bristol-Myers Squibb (NYSE: ) reported third quarter EPS of $1.80, $0.30 higher than the analyst estimate of $1.50. Income for the quarter got here in at $11.9B versus the consensus estimate of $11.26B.
Steerage
Bristol-Myers Squibb sees FY 2024 EPS of $0.75-$0.95 versus the analyst consensus of $0.71.
Bristol-Myers Squibb’s inventory worth closed at $52.66. It’s up 7.98% within the final 3 months and up 2.69% within the final 12 months.
Bristol-Myers Squibb noticed 1 optimistic EPS revisions and 17 adverse EPS revisions within the final 90 days. See Bristol-Myers Squibb’s inventory worth’s previous reactions to earnings right here.
Based on InvestingPro, Bristol-Myers Squibb’s Monetary Well being rating is “good efficiency”.
Take a look at Bristol-Myers Squibb’s , and Bristol-Myers Squibb’s financials right here.
Keep up-to-date on the entire upcoming earnings stories by visiting Investing.com’s earnings calendar